Federal contract award
W9114F23P0001
COVID-19 SARS-COV-2, CHLAMYDIA TRACHOMATIS/NEISSERIA GONORRHOEAE (CT/GC) AND HUMAN PAPILLOMA VIRUS (HPV) TESTING SUPPLIES
Award details
Obligations, current value and potential value describe different measures; they are never added together.
| Field | Reported value |
|---|---|
| Agency | Department of Defense |
| Office | W40M MRCO EUROPE |
| NAICS | 325413 — In-Vitro Diagnostic Substance Manufacturing |
| PSC | 6550 — In Vitro Diagnostic Substances, Reagents, Test Kits and Sets |
| Parent award / vehicle | Not reported |
| Set-aside | NO SET ASIDE USED. |
| Pricing type | FIRM FIXED PRICE |
| Obligations | $919.5K |
| Current contract value | $919.5K |
| Potential contract value / ceiling | $919.5K |
| Start date | Dec 8, 2022 |
| Current end date | Nov 30, 2025 |
| Potential end date | Nov 30, 2025 |
| Latest award activity | Aug 28, 2025 |
| Source loaded | Aug 15, 2026 |
Funding and modification history
Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.
| Date | Modification | Obligation change | Description |
|---|---|---|---|
| Aug 28, 2025 | P00007 | $-121.1K | CHLAMYDIA TRACHOMATIS/NEISSERIA GONORRHOEAE (CT/GC) AND HUMAN PAPILLOMA VIRUS (HPV) LABORATORY TESTING SUPPLIES FOR THE LANDSTUHL REGIONAL MEDICAL CENTER, GERMANY. |
| Nov 14, 2024 | P00006 | $301.5K | CHLAMYDIA TRACHOMATIS/NEISSERIA GONORRHOEAE (CT/GC) AND HUMAN PAPILLOMA VIRUS (HPV) LABORATORY TESTING SUPPLIES FOR THE LANDSTUHL REGIONAL MEDICAL CENTER, GERMANY. |
Research next steps
- Check the stated set-aside against the solicitation and current certifications.
- Review the award scope and buyer evidence before making a bid/no-bid decision.